D. William

发表

Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids

B. Klink, S. Löck, M. Krause, 2022, Cancers.

Initial Experience With Lung Cancer Resection Following Treatment With T Cell Checkpoint Inhibitor Therapy

V. Rusch, M. Hellmann, J. Chaft, 2017 .

Sensitization of Patient-Derived Colorectal Cancer Organoids to Photon and Proton Radiation by Targeting DNA Damage Response Mechanisms

J. Weitz, B. Klink, M. Krause, 2022, Cancers.

Synergistic Highly Potent Targeted Drug Combinations in different Pheochromocytoma Models including Human Tumor Cultures.

B. Klink, F. Beuschlein, S. Bornstein, 2019, Endocrinology.

Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents

R. Schlenk, K. Götze, P. Fenaux, 2019, Leukemia.

Patient-Derived Organoids of Cholangiocarcinoma

Lahiri Kanth Nanduri, S. Schölch, J. Weitz, 2021, International journal of molecular sciences.

Treatment of Pheochromocytoma Cells with Recurrent Cycles of Hypoxia: A New Pseudohypoxic In Vitro Model

S. Bornstein, G. Eisenhofer, M. Robledo, 2022, Cells.

Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches

E. Schröck, D. Aust, A. Rump, 2019, Cancers.

Targeted Quantification of Carbon Metabolites Identifies Metabolic Progression Markers and an Undiagnosed Case of SDH-Deficient Clear Cell Renal Cell Carcinoma in a German Cohort

E. Schröck, D. Aust, B. Klink, 2021, Metabolites.

Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.

B. Klink, F. Beuschlein, S. Bornstein, 2022, Endocrine-related cancer.

Cytogenetic Profile of 109 Lipomas Updated

Chandrika, D. McGee, P. Karakousis, 2006 .

Cytogenetic Profile of 109 Lipomas 1

Chandrika, D. McGee, P. Karakousis, 2006 .